An overview of management of narcotics and psychotropic drugs in China  

中国麻醉药品和精神药品管理概述（英文）

作　　者：姚鹏[1] 管晓东[1,2] 邓艳萍[3] 史录文[1,2] 

机构地区：[1]北京大学药学院药事管理与临床药学系,北京100191 [2]北京大学医药管理国际研究中心,北京100191 [3]北京大学中国药物依赖性研究所,北京100191

出　　处：《Journal of Chinese Pharmaceutical Sciences》2015年第4期250-256,共7页中国药学（英文版）

基　　金：financially supported by Department of Pharmacy Administration and Clinical Pharmacy,School of Pharmaceutical Sciences,Peking University

摘　　要：Narcotics and psychotropic drugs are known as controlled drugs with special management and super vision due to their psychic and physiological dependence. Based on the literature review, experts interview and policy comparative analysis, our study summarized and reviewed the status of related legislation and regulations since the enactment of the Narcotics and Psychotropic Drugs Regulations in 2005. We found the problems of legal loopholes, the complexity of supervision system and the irrational use of narcotics in the treatment of chronic non-cancer. Our analysis suggested that China should reinforce legislation, strengthen the cooperation among departments, establish the information network and improve the guideline of narcotics and psychotropic drugs for clinical treatment as quickly as possible.麻醉药品和精神药品具有精神依赖性和身体依赖性,因此各国针对其进行特殊的管制。本文通过文献调研、专家访谈和政策比较分析,全面梳理了中国2005年《麻醉药品和精神药品管理条例》颁布实施以来的相关立法、部门规章和管理办法的现状,比较分析发现法律法规存在的漏洞、监管体制的繁冗复杂、慢性非癌性疼痛麻醉药品使用规定不能满足临床需要等问题。建议中国应进一步完善立法,加强监管部门间协调合作,建立信息共享网络并完善麻醉药品和精神药品临床合理使用指南等。

关 键 词：Controlled drugs Narcotics Psychotropic drugs Supervision Management 

分 类 号：R95[医药卫生—药学]